Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies

Journal of Molecular Recognition : JMR
J Malone, M A Sullivan

Abstract

The generation of new antibodies for diagnostic applications using phage display could greatly decrease the time and expense of new assay development but, to be effective, the process must yield antibodies with desired specificity and affinity comparable to those obtained by monoclonal antibody technology. In order to evaluate the ability of the phage selection process to yield antibodies with the desired specificity and affinity, a family of anti-phenobarbital antibodies were cloned as scFvs and Fabs and displayed on M13 gene III fusion proteins. All of the antibodies are derived from similar germline VL and VH genes and exhibit extensive sequence homology except in VH CDR3. Despite these similarities, the range of panning efficiencies was observed to vary by two orders of magnitude for expressed scFvs. Unexpectedly, the scFv with the highest panning efficiency has the lowest affinity. In competitive panning experiments this scFv is preferentially isolated over higher affinity antibodies. This scFv expresses high levels of soluble binding protein while higher affinity scFvs express lower levels of protein or nonfunctional protein. These results suggest that the efficiency of functional expression of scFv proteins can greatly i...Continue Reading

References

May 1, 1991·Trends in Biotechnology·D R Burton
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C F BarbasR A Lerner
Dec 5, 1991·Journal of Molecular Biology·J D MarksG Winter
Nov 12, 1991·Biochemistry·H B LowmanJ A Wells
Jan 24, 1991·Nature·G Winter, C Milstein
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R OrlandiG Winter
Jul 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·T T Wu, E A Kabat
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·C F BarbasD R Burton

❮ Previous
Next ❯

Citations

Dec 17, 2009·Molecular Biotechnology·Tuomas HuovinenUrpo Lamminmäki
Nov 1, 2001·Journal of Immunological Methods·C G HaidarisM A Sullivan
Jun 17, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Deborah A RyanWilliam J Bowers
Jan 9, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Charles A WuertzerHoward J Federoff
Sep 19, 2012·Protein Engineering, Design & Selection : PEDS·Ido SaggyItai Benhar
Oct 22, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kathleen A Maguire-Zeiss, Howard J Federoff
Sep 21, 2013·International Journal of Molecular Sciences·Liang HuangHoward J Federoff
Jul 9, 2003·Annals of the New York Academy of Sciences·Kathleen A Maguire-Zeiss, Howard J Federoff
Apr 29, 2009·The Journal of Comparative Neurology·Howard J Federoff
Apr 28, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Guillaume CastelNoël Tordo
Aug 11, 2010·The American Journal of Pathology·Maya K DesaiWilliam J Bowers
Apr 9, 2021·Science Translational Medicine·Cassio M FontesAshutosh Chilkoti
Sep 16, 2006·Biochemical and Biophysical Research Communications·Kathleen A Maguire-ZeissHoward J Federoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

© 2021 Meta ULC. All rights reserved